PathAI Overview

PathAI is an industry leader in AI-powered precision pathology solutions that leverage deep computation and medical expertise to deliver high-quality tools pathologists use to improve diagnosis accuracy, develop life-saving medications, and improve drug development processes. PathAI trains and validates their AI models using data from over 15 million annotations from a network of 450 pathologists.

Key PathAI Features and Capabilities

• Translational Research: PathAI provides translational research tools, leveraging AI to discover biomarkers and drugs by analyzing disease pathophysiology, biomarker expression, and drug response at the tissue and cellular level. PathAI offers ready-to-deploy AI products and custom algorithm development for various diseases, supported by access to over 50 million slides and tissue samples from their network of pathology and diagnostic partners.
• Clinical Trial Services: PathAI offers comprehensive support for clinical trials, including trial-ready algorithms, lab services, and expert clinical operations. PathAI's core clinical trial services include AI-powered molecular phenotype pre-screening, extensive pathology services, and integration with their AISight platform.
• Diagnostic Development: PathAI provides diagnostic development and commercialization tools that help accelerate precision medicine strategy from development to commercial launch. These tools include custom diagnostic assays, AI-powered companion diagnostics, and SaMD that meet regional regulatory requirements. PathAI engages in strategic partnerships and market access strategies to ensure global distribution and commercialization.